Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.89
Delayed Data
As of Mar 27
 +0.105 / +1.20%
Today’s Change
2.48
Today|||52-Week Range
9.25
+40.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues4.8M4.8M7.8M9.0M
 
 
 
 
 
Cost of Goods Sold30.0K27.0K55.5K2.3M
 
 
 
 
 
Depreciation And Amortization47.0K89.0K175.0K172.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.7M4.7M7.5M6.5M
 
 
 
 
 
General Expenses23.8M16.8M16.8M14.7M
 
 
 
 
 
Research And Development20.6M14.2M14.1M12.2M
 
 
 
 
 
Total Operating Expenses23.9M16.9M17.0M17.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.0M-12.1M-9.2M-8.2M
 
 
 
 
 
Extraordinary Credit0.000.000.005.7M
 
 
Extraordinary Charge-2.8M-2.9M-931.0K--
 
 
 
 
Interest Expense On Debt1.5M1.4M1.5M2.1M
 
 
 
 
 
Other Expenses0.000.001.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.8M-16.3M-11.5M-4.5M
 
 
 
 
 
Net Income-22.8M-16.3M-11.5M-4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.6M73.7M73.7M73.8M
 
 
 
 
 
Shares To Calculate EPS Diluted73.6M73.7M73.7M73.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.22-$0.16-$0.06
 
 
 
 
 
EPS Diluted-$0.31-$0.22-$0.16-$0.06